Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/06/2008US20080275091 combination of an acid labile nonentric coated proton pump inhibitor such as omeprazole, tenatoprazole, substituted benzimidazole compounds that contain a sulfinyl group bridging substituted benzimidazole and pyridine, and a buffering agent such as NaHCO3, Al, Al/OH/3, CaCO3, night time heartburn
11/06/2008US20080275090 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/06/2008US20080275089 Compositions and methods to treat gastrointestinal disorders
11/06/2008US20080275088 Use of Collismycin and Derivatives Thereof as Oxidative Stress Inhibitors
11/06/2008US20080275087 Biphenylcarboxamides useful as lipid lowering agents
11/06/2008US20080275086 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes
11/06/2008US20080275085 Piperidine derivative and use thereof
11/06/2008US20080275084 CCR3 or H1; autoimmune, inflammatory, proliferative diseases, immunologically-mediated diseases (including rejection of transplanted organs or tissues AIDS); Ethyl 2-(4-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}piperidin-1-yl)cyclohexanecarboxylate; reacting ethyl 2-amino-1-cyclohexane carboxylate
11/06/2008US20080275083 2,3,4,9-tetrahydro-1h-carbazoles
11/06/2008US20080275082 Comprising NK3 receptor antagonist talnetant, povidone, erythritol and Sodium Lauryl Sulfate; erythritol used as soluble filler in preparation of stable drug; dosage tablet or capsule
11/06/2008US20080275081 Novel thrombomodulin expression promoters
11/06/2008US20080275080 Methods for treating lower urinary tract disorders using alpha2delta subunit channel modulators with smooth muscle modulators
11/06/2008US20080275079 M3 Muscarinic Acetylcholine Receptor Antagonists
11/06/2008US20080275078 Pyrazolo[3,4-B] Pyridine Compounds and Their Use as Pde4 Inhibitors
11/06/2008US20080275077 Pharmaceutical formulations comprising an immune response modifier
11/06/2008US20080275076 exhibit an acceptable bioavailability of sirolimus together with excipient, when administered to a mammal releases sirolimus in a controlled manner and reduces inter- and/or intra-individual variations compared to those of Rapamune (sirolimus) administered under the same condition; side effect reduction
11/06/2008US20080275075 Medicine Comprising a Combination of an Acetylcholinesterase Inhibitor and a 5-Substituted-3-Oxadiazolyl-1,6-Naphthyridin-2(1H)-One Derivative
11/06/2008US20080275074 Anti-Itching Agent
11/06/2008US20080275073 pharmaceutically acceptable salt selected from succinate, D-glucoronate, L-glucoronate, acetate, oxalate, proprionate, maleate, benzoate and citrate; protein kinase inhibitor; antitumorigenesis and anticell proliferation
11/06/2008US20080275072 Weekly administration of dipeptidyl peptidase inhibitors
11/06/2008US20080275071 Radiotherapy Enhancer
11/06/2008US20080275069 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
11/06/2008US20080275068 Method of Using Vasoconstrictive Agents During Energy-Based Tissue Therapy
11/06/2008US20080275067 5-methyl-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one; 3-(4-fluoro-phenyl)-5-methyl-2-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ethyl]-3H-quinazolin-4-one; bone-resorption disorder or a cancer of a hematopoietic origin; disorders in which PI3K plays a role in leukocyte function
11/06/2008US20080275066 3-Methanesulfonyl-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrobenzo[c]thiophene-1-carboxylic acid 2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl ester; for treatment of metabolic disorders such as IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity
11/06/2008US20080275064 N-(2-Furan-2-yl-6-pyrazol-1-yl-pyrimidin-4-yl)-2-piperidin-1-yl-acetamide; antiischemic agents, antidiabetics; autoimmune diseases, Asthma, Obesity, Huntington's Disease, Dystonia, Dyskinesias, Parkinson's Disease, Inflammatory Bowl Disease
11/06/2008US20080275063 C-{4-[6-(2-Ethoxy-phenyl)-pyrimidin-4-ylamino]-phenyl}-N-propyl-methanesulfonamide; antiinflammatories, antiproliferatives, analgesics; cardiovascular disorders, neurodegenerative diseases; immunotherapy
11/06/2008US20080275062 Benzamide rho-kinase (ROCK-1) inhibitors; N-benzyl-4-(4-pyridinyl)benzamide
11/06/2008US20080275060 N-Hydroxyamide Derivatives and Use Thereof
11/06/2008US20080275059 Novel physiologically active substances
11/06/2008US20080275058 N-Substituted-1H-Quinoline-2,4-Diones, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same
11/06/2008US20080275057 Cell cycle G2-checkpoint-abrogating 1-[(2-pyridyl)amino]-azoline-2,5-dione derivatives with at least one halogen group, to selectively sensitize cancer cells to DNA damaging reagents without additional anticarcinogenic treatment; cytolytic agents, antiproliferatives, apoptosis
11/06/2008US20080275056 Pyrazole-Isoquinoline Urea Derivatives as P38 Kinase Inhibitors
11/06/2008US20080275055 4-(4-methyl-piperazin-1-ylmethyl-benzoic acid with N-(5- amino-2-methylphenyl)-4-(3pyridyl)-2-pyrimidine-amine in the presence of a coupling reagent such as 2-(5-norborene-2,3- dicarboximido)- 1,1,3,3-tetramethyluronium tetrafluoroborate to produce imatinib, salt formation wtih methanesululfonic acid
11/06/2008US20080275054 3-(Substituted Amino)-Pyrazolo[3, 4-D]Pyrimidines as Ephb and Vegfr2 Kinase Inhibitors
11/06/2008US20080275053 Heterocyclyl Compounds
11/06/2008US20080275052 Especially p38 MAP kinase alpha and beta; 2,4-difluorophenyl(3-(2-(trifluoromethyl)phenyl)-5,6-dihydroimidazo[1,5-a]pyrazin-7(8H)-yl)methanone
11/06/2008US20080275051 Preparation of High Purity Substituted Quinoxalines
11/06/2008US20080275049 Methods and Compositions for Upregulation of GATA Activity
11/06/2008US20080275048 Substituted Diazabicycloalkane Derivates
11/06/2008US20080275047 Tetrahydro-naphthalene derivatives
11/06/2008US20080275046 1-(3-{4-[4-(piperidin-1-ylmethyl)-1,3-oxazol-2-yl]phenoxy}propyl)piperidine; 4,4-difluoro-1-[(4-methyl-2-{4-[3-(2-methylpyrrolidin-1-yl)propoxy]phenyl}-1,3-thiazol-5-yl)carbonyl]piperidine; histamine H3-receptor antagonists; Parkinson's and Alzheimer's diseases; sleep disorders; antiepileptics
11/06/2008US20080275045 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
11/06/2008US20080275044 Vanilloid receptor 1 antagonists; reducing a phenyl or 3-pyridyl carboxylic acid or ester to an alcohol, aziding, reduction to a primary amine, amidation with a (3-fluoro-4-methylsulfonamido)phenyl acetic acid; 2-(3-Fluoro-4-(methylsulfonamido)phenyl)-N-(substituted phenyl or pyrid-3-yl) acetamides
11/06/2008US20080275043 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1
11/06/2008US20080275042 4-Phenyl-5-Oxo-1,4,5,6,7,8-Hexahydroquinoline Derivatives for the Treatment of Infertility
11/06/2008US20080275041 3-[5-({4-[2-(Dipropylamino)ethyl]piperazin-1-yl}sulfonyl)pyridin-2-yl]-2-hydroxy-1H-indole-6-carbonitrile hydrochloride; Alzheimer's Disease, Parkinson's Disease, depression, schizophrenia, HIV, Down syndrome, bone disorders, alopecia
11/06/2008US20080275040 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders
11/06/2008US20080275039 Geldanamycin Derivatives and the Method for Biosynthesis Thereof
11/06/2008US20080275038 Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275036 Prevention and treatment of cardiac conditions
11/06/2008US20080275035 Nitroimidazole Compounds
11/06/2008US20080275034 having a calpain inhibiting activity and an activity which traps the reactive oxygen species (ROS); for protecting acoustic hair cells;
11/06/2008US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
11/06/2008US20080275032 Pyridazinone compounds
11/06/2008US20080275031 Inhibitors of C-FMS Kinase
11/06/2008US20080275030 Methods and Compositions for the Delivery of a Therapeutic Agent
11/06/2008US20080275029 Compounds for Treating Protein-Kinase Mediated Disorders
11/06/2008US20080275028 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
11/06/2008US20080275027 Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists
11/06/2008US20080275026 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
11/06/2008US20080275025 Substituted Lactams and Their Use as Anti-Cancer Agents
11/06/2008US20080275024 Amyloid precursor protein/gamma-secretase inhibitors; amides of aminobenzodiazepines: 2-(3,5-difluorophenyl)-N {[N-(1-methyl-2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))carbamoyl]cyclohexyl}acetamide
11/06/2008US20080275023 N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations
11/06/2008US20080275022 Substituted Quinazolones as Anti-Cancer Agents
11/06/2008US20080275021 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
11/06/2008US20080275020 Pharmaceutical formulation
11/06/2008US20080275019 Metal complex protein kinase inhibitors
11/06/2008US20080275018 Antibacterial amide-macrocycles v
11/06/2008US20080275017 Aromatic sulfenates for type i phototherapy
11/06/2008US20080275016 For drug resistant cancers; antiinflammatory agents;degenerative or vascular diseases; blocking nitrogen oxide so growth of tumors is suppressed
11/06/2008US20080275015 Aqueous solution directly into bladder; mixture of an antihistamine, steroid antiinflammatory drug, anticonvulsant, and amino acid
11/06/2008US20080275013 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders
11/06/2008US20080275012 Mixture of androgen, such as testosterone, macrocyclic ketone enhancer and thickener; therapy for glandular disorders
11/06/2008US20080275011 Synergistic mixture; mycardial infraction; cardiovascular disorders
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/06/2008US20080275009 Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
11/06/2008US20080275008 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/06/2008US20080275007 Charged phospholipid compositions and methods for their use
11/06/2008US20080275006 Process for the Preparation and Isolation of Phosphatides
11/06/2008US20080275005 Mitochondrially targeted antioxidants
11/06/2008US20080275004 N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/06/2008US20080275003 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
11/06/2008US20080275002 Method for Treatment of Hepatic Cancer
11/06/2008US20080275001 Enhanced bioavailability, absorption; using fartty acid, or salt thereof, or fatty ester; sustained release; drug is anticaogulant
11/06/2008US20080275000 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
11/06/2008US20080274999 Cosmetics; low molecular weight; therapy for osteoarthritis
11/06/2008US20080274998 Adjust biological activity of moesin by binding; parasiticides; bactericides; central nervous system disorders; Down's syndrome; antiinflamamtory agents; anticancer agents; autoimmune diseases; skin disorders; gastrointestinal disorders
11/06/2008US20080274997 Fluid bed granulation process; water soluble grains; solid oral drug
11/06/2008US20080274996 Therapy for cancer; Alzheimer's disease; using Rna sequences; control degradation , block translation of messenger Rna ; transcription product of target gene encoding clusterin
11/06/2008US20080274995 Suppression of Nuclear Factor-KappaB Dependent Processes Using Oligonucleotides
11/06/2008US20080274994 Dna sequence and genomic structure of human cardiac isoform; gene or allele mutants associated with cardiovascular disorders; reduce stretch activation and adjust tension of muscles in heart contraction; isolated nucleic acid encoding a protein
11/06/2008US20080274993 Methods and compositions for modulating vascular integrity
11/06/2008US20080274992 Vectors encoding immunogens; human t-cell leukemia,lymphoma virus vaccine
11/06/2008US20080274991 Nucleic Acids Against Viruses, in Particular Hiv
11/06/2008US20080274990 Cog47 Protein and S100beta Gene Polymorphism
11/06/2008US20080274989 Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
11/06/2008US20080274988 Microarray-Mediated Diagnosis of Herpes Virus Infection by Monitoring Host's Differential Gene Expression Upon Infection
11/06/2008US20080274987 Novel alpha glucosidase activator, pulicarside 1
1 ... 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 3028 ... 7860